Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Government of Canada was posted on July 26, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ACAN Buprenorphine

Closed
WS4696007433International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is soliciting quotes for a one-time purchase of antibiotics to be stockpiled for post-exposure response to Category A agents, including anthrax, plague, and tularemia. The requirement consists of 30,000 tablets of Ciprofloxacin Hydrochloride (500mg/dose) and 200,000 tablets of Doxycycline Monohydrate (100mg/dose). All products must be FDA approved and comply with CDC and California Department of Public Health standards. Strict adherence to cold-chain storage and temperature-controlled guidelines is required, with the use of temperature-monitoring devices during transit and full lot-level traceability from production to delivery. The contract must be completed within the city's fiscal year ending June 30, 2027, with a required delivery lead time of four business days from the date of order to the delivery location at 1845 N Fair Oaks Ave, Pasadena, CA. Bidders must submit pricing electronically via the city's eProcurement Portal, ensuring that quoted unit prices include all delivery costs and sales tax, as no separate freight or handling fees will be accepted. The response deadline is November 4, 2026. Compliance requirements include the submission of a Unique Entity Identifier (UEI), IRS Form W-9, and various vendor questionnaires regarding equal opportunity and legal status. The procurement is subject to federal regulations, including FEMA terms and conditions, the Davis-Bacon Act for prevailing wages, and the Byrd Anti-Lobbying Amendment. Award will be based on the ability to deliver the specified antibiotics at a competitive price while meeting all regulatory, insurance, and technical specifications.
Public Health Department

POSTED

2 days ago

DEADLINE

in 5 days

AI Contract Overview

Show more

Public Services and Procurement Canada is establishing a National Master Standing Offer with Indivior UK Ltd. to provide buprenorphine extended-release injection solution. This procurement is conducted on behalf of Correctional Service Canada to support the treatment of opioid dependence across Canada. The agreement covers the supply of up to 6,200 doses per year, which will be delivered on an as-needed basis. This solicitation, identified by number WS4696007433, was posted on July 26, 2024, with a response deadline of August 8, 2024.

General Info

Indivior UK Ltd will supply buprenorphine injections for Correctional Service Canada opioid treatment.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Public Works and Government Services
Contacts1 person available
OfficeN/A
Office AddressN/A
Contacts
Bissonnette Suzanne (SPAC/PSPCPoint of Contact

Full Description

Show more
Public Services and Procurement Canada intends to establish a National Master Standing Offer with Indivior UK Ltd. Canada) on behalf of Correctional Service Canada (CSC) for the supply of buprenorphine extended-release injection solution for the treatment of opioid dependence. This requirement is to supply up to 6,200 doses/year to be delivered as and when required.

More opportunities from Government of Canada → Department of Public Works and Government Services

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS